| 1. |  4D Pharma plc Leeds, United Kingdom | Biotech | Preclinical to Phase II (at time of administration) | VIEW |
| 2. |  ABX advanced biochemical compounds Radeberg, Germany | CDMO | Commercial | VIEW |
| 3. |  Acelot South San Francisco, California, USA | Biotech | Preclinical | VIEW |
| 4. |  Adamed Pharma Pieńków, Poland | Pharma | Commercial | VIEW |
| 5. |  Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA) | Biotech | Clinical | VIEW |
| 6. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 7. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 8. |  Akkodis Zurich, Switzerland | CRO | Commercial | VIEW |
| 9. |  | CDMO | Commercial | VIEW |
| 10. |  All India Institute of Medical Sciences, Raipur Raipur, India | Diagnostics | Commercial | VIEW |
| 11. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 12. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 13. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 14. |  Amgen Thousand Oaks, California, United States | Pharma | Discovery through Commercial | VIEW |
| 15. |  Ami Organics Limited Surat, India | CDMO | Commercial | VIEW |
| 16. |  Anavex Life Sciences Corp. New York, United States | Biotech | Phase 2|Phase 3 | VIEW |
| 17. |  Anthem Biosciences Bangalore, India | CDMO | Commercial | VIEW |
| 18. |  AskGene Camarillo, California, United States | Biotech | Phase 3 | VIEW |
| 19. |  Aspen Pharmacare Holdings Limited uMhlanga, South Africa | Pharma | Commercial (Focus on post-patent branded generics rather than R&D pipeline) | VIEW |
| 20. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 21. |  AstraZeneca Cambridge, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 22. |  Aurigon Labs Munich, Germany | CRO | Preclinical | VIEW |
| 23. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 24. |  Avenzo Therapeutics San Diego, USA | Biotech | Phase 2 | VIEW |
| 25. |  | Pharma | Discovery through Commercial | VIEW |
| 26. |  BeOne Medicines (formerly BeiGene) Cambridge, Massachusetts, United States (corporate); Basel, Switzerland (post-redomiciliation May 2025) | Biotech | Phase 1-3 and Commercial | VIEW |
| 27. |  Beckman Coulter Life Sciences Indianapolis, USA | MedTech | Commercial | VIEW |
| 28. |  Becton Dickinson Franklin Lakes, New Jersey, USA | MedTech | Commercial | VIEW |
| 29. |  BenevolentAI London, United Kingdom | Biotech | Phase 1|Phase 2|Preclinical | VIEW |
| 30. |  Berg Health Framingham, Massachusetts, USA | Biotech | Phase 1/2 | VIEW |
| 31. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 32. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 33. |  Biolab Samut Prakan, Thailand | CDMO | Commercial | VIEW |
| 34. |  Blanchard Valley Health System Findlay, USA | MedTech | Commercial | VIEW |
| 35. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 36. |  Boston Institute of Biotechnology Southborough, USA | CDMO | Commercial | VIEW |
| 37. |  Bracco Imaging S.p.A. Milan, Italy | Pharma | Commercial | VIEW |
| 38. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 39. |  | Digital Health | Commercial | VIEW |
| 40. |  | Digital Health | Commercial | VIEW |
| 41. |  CDR-Life Schlieren, Zurich, Switzerland | Biotech | Phase 1 | VIEW |
| 42. |  CECOS University of Information Technology and Emerging Sciences Peshawar, Pakistan | Biotech | Preclinical | VIEW |
| 43. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 44. |  CERNO Eeklo (Ghent region), Belgium | CRO | Commercial | VIEW |
| 45. |  CEVA Logistics Marseille, France | CRO | Commercial | VIEW |
| 46. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 47. |  CMC Pharmaceuticals Solon, Ohio, USA | CDMO | Commercial | VIEW |
| 48. |  | Digital Health | Commercial | VIEW |
| 49. |  Cadence Design Systems San Jose, USA | Digital Health | Commercial | VIEW |
| 50. |  Calico Life Sciences South San Francisco, United States | Biotech | Phase 2 | VIEW |
| 51. |  Cambridge Consultants Cambridge, United Kingdom | MedTech | Commercial | VIEW |
| 52. |  | Biotech | Phase 1 - Phase 2 | VIEW |
| 53. |  | Digital Health | Commercial | VIEW |
| 54. |  Carbogen Amcis Bubendorf, Switzerland | CDMO | Commercial | VIEW |
| 55. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 56. |  Celltrion Incheon, South Korea | Pharma | Commercial | VIEW |
| 57. |  Celularity Inc Florham Park, New Jersey, USA | Biotech | Phase 1/2 and Phase 2 | VIEW |
| 58. |  Cencora Conshohocken, Pennsylvania, USA | Pharma | Commercial | VIEW |
| 59. |  Cencora Conshohocken, Pennsylvania, United States | Pharma | Commercial (as distributor/logistics provider) | VIEW |
| 60. |  Centogene Rostock, Germany | Diagnostics | Preclinical | VIEW |
| 61. |  Cerbios-Pharma SA Barbengo-Lugano, Switzerland | CDMO | Preclinical|Clinical|Commercial | VIEW |
| 62. |  Cerebras Systems Sunnyvale, USA | Digital Health | Commercial | VIEW |
| 63. |  Chengdu Kanghong Pharmaceutical Group Chengdu, China | Biotech | Commercial | VIEW |
| 64. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 65. |  China Medical University Hospital (CMUH) Taichung, Taiwan | Biotech | Phase 2 | VIEW |
| 66. |  Chinese Medical Association Publishing House (CMAPH) Beijing, China | Digital Health | Commercial | VIEW |
| 67. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 68. |  Chongqing PegBio Biotechnology Co., Ltd. Chongqing, China | Biotech | Phase 3 | VIEW |
| 69. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 70. |  Chung-Ang University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 71. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 72. |  Circio Holding ASA Lysaker, Norway | Biotech | Phase 1/2 | VIEW |
| 73. |  City of Hope Duarte, California, USA | Biotech | Commercial | VIEW |
| 74. |  Clasp Therapeutics Rockville, Maryland, USA | Biotech | Phase 1 | VIEW |
| 75. |  Cliantha Research Ahmedabad, India | CRO | Commercial | VIEW |
| 76. |  Clinical Horizons Research Inc. Leonia, New Jersey, USA | CRO | Commercial | VIEW |
| 77. |  Compal Electronics, Inc. Taipei, Taiwan | MedTech | Phase 2 | VIEW |
| 78. |  Constructor Group Schaffhausen, Switzerland | Biotech | Preclinical | VIEW |
| 79. |  Crixmor LLC Malvern, Pennsylvania, USA | Biotech | Discovery | VIEW |
| 80. |  | Biotech | Phase 1 | VIEW |
| 81. |  Curadev Pharma Pvt Ltd Noida, India | Biotech | Phase 1 | VIEW |
| 82. |  Curasight Copenhagen, Denmark | Biotech | Phase 1-2 Clinical | VIEW |
| 83. |  Curatis Liestal, Switzerland | Biotech | Phase 3 | VIEW |
| 84. |  Curestack Tampa, Florida, USA | Digital Health | Commercial | VIEW |
| 85. |  Cuttsy+Cuttsy Cambridge, United Kingdom | CRO | N/A (Service Provider) | VIEW |
| 86. |  Cyborg Advisor New York, USA | Digital Health | Commercial | VIEW |
| 87. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 88. |  | CRO | Service Provider | VIEW |
| 89. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 90. |  CytoAgents Pittsburgh, USA | Biotech | Phase 2 | VIEW |
| 91. |  CytoDyn Inc Vancouver, Washington | Biotech | Phase 2 clinical | VIEW |
| 92. |  CytoImmune Therapeutics Duarte, USA | Biotech | Phase 1 | VIEW |
| 93. |  CytoSen Therapeutics Orlando (Winter Springs), Florida, USA | Biotech | Phase 2 | VIEW |
| 94. |  CytoTools AG Heidelberg, Germany | Biotech | Phase 3 | VIEW |
| 95. |  | Biotech | Phase 2 | VIEW |
| 96. |  Cytocom, Inc. Fort Collins, Colorado, USA | Biotech | Phase 2/Phase 3 | VIEW |
| 97. |  CytomX Therapeutics, Inc. South San Francisco, California, United States | Biotech | Phase 1 (clinical), Preclinical (discovery collaborations) | VIEW |
| 98. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 99. |  Cytorex Biosciences Weston, Florida, USA | Biotech | Preclinical | VIEW |
| 100. |  | Biotech | Phase I/II - Phase II | VIEW |
| 101. |  Cytovia Therapeutics Aventura, Florida, USA | Biotech | Phase 1/2 | VIEW |
| 102. |  Daiichi Sankyo Chuo, Tokyo, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 103. |  Dendreon Pharmaceuticals Seal Beach, USA | Biotech | Commercial | VIEW |
| 104. |  Development Center for Biotechnology (DCB) Taipei, Taiwan | Biotech | Preclinical | VIEW |
| 105. |  Dexcel Pharma Or Akiva, Israel | Biotech | Commercial | VIEW |
| 106. |  Divi's Laboratories Limited Hyderabad, India | CDMO | Commercial | VIEW |
| 107. |  Dr. Reddy's Laboratories Ltd. Hyderabad, India | Pharma | Commercial | VIEW |
| 108. |  E-Flask Seongnam, South Korea | Biotech | Phase 1 | VIEW |
| 109. |  | CRO | Commercial | VIEW |
| 110. |  | CDMO | Commercial | VIEW |
| 111. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 112. |  EUBREAST Esslingen, Germany | Biotech | Phase 3 | VIEW |
| 113. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 114. |  Edge Therapeutics, Inc. Princeton, New Jersey, USA | Biotech | Phase 3 | VIEW |
| 115. |  Efficient Pharma Management Corp. (EffPha) Taipei City, Taiwan | CRO | Commercial | VIEW |
| 116. |  Elevance Health Indianapolis, USA | Digital Health | Commercial | VIEW |
| 117. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 118. |  Ellipses Pharma London, United Kingdom | Biotech | Phase 1/2 | VIEW |
| 119. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 120. |  Evinova Cambridge, United Kingdom (Regional offices in North America, Europe, and Asia-Pacific) | Digital Health | Commercial | VIEW |
| 121. |  Export-Import Bank of Korea Seoul, South Korea | Pharma | Commercial | VIEW |
| 122. |  FFF Enterprises, Inc. Temecula, USA | CDMO | Commercial | VIEW |
| 123. |  | Pharma | Commercial | VIEW |
| 124. |  Fidelity Investments Boston, USA | Pharma | Commercial | VIEW |
| 125. |  Flare Therapeutics Cambridge, MA, USA | Biotech | Phase 1-1B | VIEW |
| 126. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 127. |  Fosun Pharma Shanghai, China | Pharma | Commercial | VIEW |
| 128. |  Fusion Antibodies Belfast, Northern Ireland, United Kingdom | CRO | Discovery|Preclinical|Clinical (clients' projects) | VIEW |
| 129. |  Fusion Pharmaceuticals Inc. Hamilton, Ontario, Canada | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 130. |  GE HealthCare Chicago, USA (Global); Lindesnes/Oslo, Norway (PDx R&D/Manufacturing) | MedTech | Commercial | VIEW |
| 131. |  GSK plc London, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 132. |  Gan & Lee Pharmaceuticals Beijing, China | Biotech | Commercial | VIEW |
| 133. |  GenAns Biotech Beijing, China | Biotech | Preclinical | VIEW |
| 134. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 135. |  Getz Pharma Karachi, Pakistan | Pharma | Commercial | VIEW |
| 136. |  GlobalData Plc London, United Kingdom | Digital Health | Commercial | VIEW |
| 137. |  Gypto Pharma Khanka, Qalyubia, Egypt | CDMO | Commercial | VIEW |
| 138. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 139. |  | CRO | Commercial | VIEW |
| 140. |  HDS Formación Barcelona, Spain | Digital Health | Commercial | VIEW |
| 141. |  Harvest Integrated Research Organization Shanghai, China | CRO | N/A - Service provider, not drug developer | VIEW |
| 142. |  Hemerion Therapeutics Villeneuve d'Ascq, France | Biotech | Phase 1/2 | VIEW |
| 143. |  Hikma Pharmaceuticals London, United Kingdom | Pharma | Commercial | VIEW |
| 144. |  | Digital Health | Commercial | VIEW |
| 145. |  Hone Bio Bristol, United Kingdom | Biotech | Preclinical | VIEW |
| 146. |  Hospital Israelita Albert Einstein São Paulo, Brazil | Diagnostics | Commercial | VIEW |
| 147. |  ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain | CRO | N/A (Service Provider) | VIEW |
| 148. |  | CRO | Commercial | VIEW |
| 149. |  Immunomic Therapeutics, Inc. Rockville, Maryland, United States | Biotech | Phase 1 - Phase 2 | VIEW |
| 150. |  Infinitopes Oxford, United Kingdom | Biotech | Phase 1/IIa | VIEW |
| 151. |  Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France | Diagnostics | Clinical Care & Translational Research | VIEW |
| 152. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 153. |  IntuitionLabs San Jose, California, USA | Digital Health | Commercial | VIEW |
| 154. |  Istituto Oncologico Veneto (IOV) Padua, Italy | Diagnostics | Phase 3 | VIEW |
| 155. |  Italfarmaco Group Milan, Italy | Pharma | Commercial | VIEW |
| 156. |  JOINN Laboratories Beijing, China | CRO | Commercial | VIEW |
| 157. |  JSB Solutions Srl Sesto Fiorentino (Florence), Italy | CRO | Commercial | VIEW |
| 158. |  Jamp Pharma Group Boucherville, Canada | Pharma | Commercial | VIEW |
| 159. |  Janux Therapeutics San Diego, California, USA | Biotech | Phase 1 | VIEW |
| 160. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Commercial | VIEW |
| 161. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 162. |  Junshi Biosciences Shanghai, China | Biotech | Commercial | VIEW |
| 163. |  KMK Consulting Inc. Morristown, New Jersey, USA | CRO | Commercial | VIEW |
| 164. |  Katrina Rogers Consulting LLC Spokane, Washington, USA | CRO | Commercial | VIEW |
| 165. |  Komtur Pharmaceuticals Freiburg, Germany | CRO | Commercial | VIEW |
| 166. |  Kura Oncology Inc San Diego, California, USA | Biotech | Phase 1|Phase 2|Phase 3|Approved | VIEW |
| 167. |  LGM Pharma Boca Raton, USA | CDMO | Commercial | VIEW |
| 168. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 169. |  Laboratorios Bagó Buenos Aires, Argentina | Biotech | Commercial | VIEW |
| 170. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 171. |  Lifespan (now Brown University Health) Providence, USA | Pharma | Commercial | VIEW |
| 172. |  | CDMO | Commercial | VIEW |
| 173. |  Lyncmed (Beijing) Biotech Co., Ltd. Beijing, China | Diagnostics | Commercial | VIEW |
| 174. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 175. |  | Biotech | Commercial/Phase 3 | VIEW |
| 176. |  Medac Pharm / medac GmbH Wedel, Germany (near Hamburg) | Pharma | Commercial|Phase 2|Preclinical | VIEW |
| 177. |  Medical University of Silesia Katowice, Poland | Diagnostics | Commercial | VIEW |
| 178. |  Medison Pharma Petah Tikva, Israel | Biotech | Commercial | VIEW |
| 179. |  Menarini Stemline New York, USA | Biotech | Commercial | VIEW |
| 180. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 181. |  Metagenomi Emeryville, USA | Biotech | Preclinical | VIEW |
| 182. |  | Biotech | Preclinical | VIEW |
| 183. |  | Biotech | Commercial | VIEW |
| 184. |  N4 Pharma Chellaston, Derbyshire, United Kingdom | Biotech | Preclinical | VIEW |
| 185. |  NBE Therapeutics Basel, Switzerland | Biotech | Phase 1/2 | VIEW |
| 186. |  NPDK Bioconsulting San Diego, California | CRO | Commercial | VIEW |
| 187. |  Nagase & Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 188. |  Nanjing Vazyme Biotech Co., Ltd. Nanjing, China | Diagnostics | Commercial | VIEW |
| 189. |  Nanocan Therapeutics Corporation Princeton, New Jersey (also noted as National Harbor, MD) | Biotech | Phase I/II | VIEW |
| 190. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 191. |  Nutshell Therapeutics Shanghai, China (Pudong District, Building E, No. 1976 Middle Gaoke Road) | Biotech | Preclinical to Phase 1 | VIEW |
| 192. |  Nuvation Bio New York, United States | Biotech | Commercial | VIEW |
| 193. |  ONO PHARMA UK LTD London, United Kingdom | Pharma | Phase 1 through Commercial | VIEW |
| 194. |  ONO Pharmaceutical Osaka, Japan (Chuo-ku) | Pharma | Phase 1-Phase 3 | VIEW |
| 195. |  OPIS (a KCR Group Company) Desio (Milan), Italy | CRO | Commercial | VIEW |
| 196. |  On/Off Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 197. |  Oncotelic Therapeutics Agoura Hills, California, USA | Biotech | Phase 1|Phase 2|Phase 3 | VIEW |
| 198. |  Optum Eden Prairie, Minnesota, USA | Digital Health | Commercial | VIEW |
| 199. |  Oracle Corporation Austin, Texas, USA | Pharma | Commercial | VIEW |
| 200. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 201. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 202. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 203. |  Phanes Therapeutics San Diego, California, USA | Biotech | Phase 1/2 | VIEW |
| 204. |  Phanes Therapeutics, Inc. San Diego, California, USA | Biotech | Phase 1/2 | VIEW |
| 205. |  Philips Amsterdam, Netherlands | MedTech | Commercial | VIEW |
| 206. |  PhoMedics Hong Kong Science Park, Hong Kong | MedTech | Commercial | VIEW |
| 207. |  Pierre Fabre Group Castres, France | Pharma | Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 208. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 209. |  Process Automation Solutions (PA) Ludwigshafen, Germany / Greenville, SC, USA | CDMO | Commercial | VIEW |
| 210. |  | CRO | Commercial | VIEW |
| 211. |  | Biotech | Phase 2 | VIEW |
| 212. |  | Biotech | Phase 1 | VIEW |
| 213. |  Renata PLC Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 214. |  Revolution Medicines Redwood City, USA | Biotech | Phase 3 | VIEW |
| 215. |  Ribon Therapeutics Cambridge, MA, United States | Biotech | Phase 1/2 | VIEW |
| 216. |  Ridgeline Discovery Basel, Switzerland | Biotech | Discovery|Preclinical|Phase 1|Phase 2 | VIEW |
| 217. |  | Pharma | Commercial | VIEW |
| 218. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 219. |  | CRO | Commercial | VIEW |
| 220. |  SSM Health St. Louis, United States | Digital Health | Commercial | VIEW |
| 221. |  | Digital Health | Commercial | VIEW |
| 222. |  Sai Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 223. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 224. |  Scenic Biotech Amsterdam, The Netherlands | Biotech | Preclinical to IND-enabling | VIEW |
| 225. |  ScinoPharm Taiwan Ltd. Tainan, Taiwan | CDMO | Commercial | VIEW |
| 226. |  | Biotech | Commercial | VIEW |
| 227. |  Senti Biosciences South San Francisco, California, USA | Biotech | Phase 1 | VIEW |
| 228. |  Sentinel Oncology Cambridge, United Kingdom | Biotech | Preclinical to Phase 1 | VIEW |
| 229. |  Shanghai Jeyou Pharmaceutical Co., Ltd. Shanghai, China (Pudong district) | Biotech | Preclinical to Phase 2 | VIEW |
| 230. |  Siegfried Holding AG Zofingen, Switzerland | CDMO | Commercial | VIEW |
| 231. |  | Pharma | Commercial | VIEW |
| 232. |  Sinotherapeutics Inc. Shanghai, China | Biotech | Commercial | VIEW |
| 233. |  Southern Taiwan University of Science and Technology (STUST) Tainan City, Taiwan | Biotech | Preclinical | VIEW |
| 234. |  Square Pharmaceuticals PLC Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 235. |  Standard Research Institute (SRI) Karaj, Iran | Diagnostics | Discovery | VIEW |
| 236. |  | Biotech | Phase 1/Phase 2 | VIEW |
| 237. |  StemSynergy Therapeutics Miami, Florida, USA | Biotech | Preclinical and IND-enabling | VIEW |
| 238. |  Stemline Therapeutics, Inc. New York, United States | Biotech | Commercial + Clinical Development | VIEW |
| 239. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 240. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 241. |  TAE Life Sciences Irvine, California, United States | Biotech | Investigator Initiated Trials (IIT) - Early clinical stage | VIEW |
| 242. |  TVAX Biomedical, Inc. Lenexa, Kansas, United States | Biotech | Phase 2b/3 | VIEW |
| 243. |  TYG Oncology Mansfield, Nottinghamshire, United Kingdom | Biotech | Phase 1 | VIEW |
| 244. |  Tagworks Pharmaceuticals Nijmegen, Netherlands | Biotech | Phase 1 | VIEW |
| 245. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 246. |  Tamkang University New Taipei City, Taiwan | Biotech | Discovery | VIEW |
| 247. |  The ConfluenceElite Group, LLC Greater Philadelphia Area, USA | CRO | Commercial | VIEW |
| 248. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 249. |  Think Quality LLC Westborough, Massachusetts, USA | CRO | Commercial | VIEW |
| 250. |  Tongji University Shanghai, China | Biotech | Phase 3 | VIEW |
| 251. |  Torrent Pharmaceuticals Ahmedabad, India | Pharma | Commercial | VIEW |
| 252. |  Tvardi Therapeutics Inc Sugar Land/Houston, Texas, USA | Biotech | Phase 2 | VIEW |
| 253. |  UK Biobank Stockport, United Kingdom | Diagnostics | Commercial | VIEW |
| 254. |  Unicancer France (Federated across 20 hospital sites) | CRO | Phase 1 through Phase 4 (Clinical trials at all stages) | VIEW |
| 255. |  Universitas Indonesia Depok, Indonesia | CRO | Phase 3 | VIEW |
| 256. |  Universitas Sebelas Maret Surakarta, Indonesia | Diagnostics | Phase 2 | VIEW |
| 257. |  University of British Columbia Vancouver, Canada | Biotech | Discovery | VIEW |
| 258. |  University of California, Berkeley Berkeley, USA | Biotech | Discovery | VIEW |
| 259. |  University of Cincinnati Cincinnati, USA | Biotech | Commercial | VIEW |
| 260. |  University of Colorado Boulder Boulder, USA | Biotech | Discovery | VIEW |
| 261. |  University of Wisconsin–Madison Madison, USA | Biotech | Commercial | VIEW |
| 262. |  Vandalia Health Charleston, United States | MedTech | Commercial | VIEW |
| 263. |  Viatris Canonsburg, Pennsylvania, United States | Pharma | Phase 1 to Commercial | VIEW |
| 264. |  Virchow Healthcare Mumbai, India | CDMO | Commercial | VIEW |
| 265. |  | Biotech | Phase 3 | VIEW |
| 266. |  Whyze Health Dublin, Ireland | Digital Health | Commercial | VIEW |
| 267. |  WriteSource Medical Pty Ltd North Sydney, Australia | CRO | Commercial | VIEW |
| 268. |  Yeditepe University Istanbul, Turkey | Biotech | Phase 3 | VIEW |
| 269. |  Yifan Pharmaceutical Co., Ltd. Hangzhou, China | Pharma | Phase 2-3, Commercial | VIEW |
| 270. |  Zenagem Philadelphia, Pennsylvania | Biotech | Discovery | VIEW |
| 271. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 272. |  iDigiPath Solutions Kochi, India | Digital Health | Discovery | VIEW |
| 273. |  iRT Systems GmbH Koblenz, Germany | MedTech | Commercial | VIEW |